Hepatitis B: causes, transmission, diagnosis, prevention and treatment

Transmission

The virus is transmitted when infectious blood or certain body fluids enter the bloodstream of an uninfected person. Common routes include:

• Perinatal transmission from mother to baby during childbirth.
• Unprotected sexual contact with an infected person.
• Sharing or reusing contaminated needles or injecting equipment.
• Transfusion with infected blood or blood products (largely controlled now by screening).
• Occupational or accidental exposure to infected blood; transmission is not associated with casual contact or contaminated food.

Clinical course and symptoms

After exposure there may be a variable incubation period before symptoms appear. Many people—especially children—have few or no noticeable symptoms, while others experience fatigue, abdominal discomfort, dark urine, and jaundice, a yellowing of the skin and the eyes. Severe acute infection can progress to liver failure, although this is uncommon. When infection persists beyond several months it is classified as chronic and carries long-term risks.

Diagnosis

Diagnosis is made with laboratory testing of blood. Routine panels look for viral surface antigen and antibody patterns and for viral genetic material; these blood tests distinguish acute from chronic infection and indicate immunity. Monitoring may include liver function tests and measurement of viral load to guide management and detect progressive liver injury.

Prevention

Prevention combines vaccination, safe practices, and screening. A safe and effective vaccine is available and is given by injection. Public health programs generally recommend a primary vaccine series beginning in infancy, which produces strong protection for most people. Other measures include screening blood donations, using sterile injection equipment, safer-sex practices, and, after known exposure, prompt medical evaluation for post-exposure prophylaxis.

Treatment and prognosis

Treatment depends on whether the infection is acute or chronic. Many acute cases require supportive care only, as the immune system clears the virus. Chronic hepatitis B can be managed with antiviral medications that suppress viral replication and reduce the risk of progressive liver damage; long-term monitoring is often needed. Though current therapies can control the virus, complete eradication from infected liver cells is difficult, so lifelong follow-up may be necessary for some patients.

Public health, screening and notable facts

Global strategies focus on universal infant immunization, screening of pregnant people to prevent perinatal transmission, and harm-reduction programs for people who inject drugs. Awareness campaigns emphasize that hepatitis B is a vaccine-preventable disease and that early diagnosis through testing improves outcomes. For more detailed guidance on prevention and care see national and international public health resources and clinical guidelines.

For additional information and official recommendations, consult healthcare providers or reputable health organizations represented in public guidance portals, and consider targeted resources on vaccination, maternal screening, and antiviral treatment options.

link1 link2 link3 link4 link5 link6 link7 link8 link9 link10 link11 link12 link13 link14 link15 link16 link17